Francesco Schettini

4.6k citations
113 papers · 2.0k indexed · 1 hit paper · h-index 22

Impact in

  • Genetics top 5%
    • Hemoglobinopathies and Related Disorders
    • Chronic Lymphocytic Leukemia Research
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Cancer-related Molecular Pathways

Papers in

    • Breast Cancer Treatment Studies 32
    • Cancer Genomics and Diagnostics 8
    • HER2/EGFR in Cancer Research 30
    • Cancer Treatment and Pharmacology 17

Francesco Schettini

100 papers receiving 1.9k citations

Hit Papers

Frequency and spectrum of PIK3CA somatic mutations in breast cancer 2020 · 227 citations
227202020262022202450100150200

Peers

Francesco Schettini
Comparison fields: 5 of 101
  • Genetics 350
  • Oncology 861
  • Cancer Research 463
  • Hematology 255
  • Pulmonary and Respiratory Medicine 641
Replace George F. Tidmarsh with:
George F. Tidmarsh United States
Ellis Levine United States
Ye Guo China
Toshinari Yamashita Japan
Urban Emmenegger Canada
Peter Krippl Austria
William J. Edenfield United States
Don V. Jackson United States
Gerald W. Prager Austria
S.C. Henzen‐Logmans Netherlands
Francesco Schettini relative to George F. Tidmarsh United States George F. Tidmarsh's profile →
Citations per field
00.5×3.2×
George F. Tidmarsh · 1×
Citations per year

Countries citing papers authored by Francesco Schettini

Since Specialization
Citations

This map shows the geographic impact of Francesco Schettini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Schettini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Schettini more than expected).

Fields of papers citing papers by Francesco Schettini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Schettini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Schettini. The network helps show where Francesco Schettini may publish in the future.

Co-authors

The 25 scholars most cited alongside Francesco Schettini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Francesco Schettini Line = papers co-authored together Francesco Schettini links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20244
3 20240
4 20249
5 20241
6 20244
7 20231
8 20238
9 20230
10 20230
11 20235
12 20239
13 202225
14 202214
15 202175
16 202062
17 202012
18 202010
19 2019119
20 201820

About Francesco Schettini

Francesco Schettini is a scholar working on Cancer Research, Oncology, Hematology, Genetics and Pulmonary and Respiratory Medicine, having authored 113 papers that have together received 2.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (32 papers), Advanced Breast Cancer Therapies (31 papers), HER2/EGFR in Cancer Research (30 papers), Cancer Treatment and Pharmacology (17 papers), Hemoglobinopathies and Related Disorders (11 papers), Neonatal Health and Biochemistry (8 papers), Cancer Genomics and Diagnostics (8 papers) and Iron Metabolism and Disorders (8 papers). The work is most often cited by research in Genetics (350 citations), Oncology (861 citations), Cancer Research (463 citations), Hematology (255 citations) and Pulmonary and Respiratory Medicine (641 citations). Francesco Schettini has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Aleix Prat, Sabino De Placido, Grazia Arpino, Mario Giuliano, Lucia Del Mastro, Fara Brasó‐Maristany, Fabio Puglisi, Michelino De Laurentiis, Pietro De Placido and Tomás Pascual. Their work appears in journals such as Annals of Oncology, ESMO Open, Acta Haematologica, The Breast and Cancer Treatment Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026